Cas:154-17-6 2-Deoxy-D-glucose manufacturer & supplier

We serve Chemical Name:2-Deoxy-D-glucose CAS:154-17-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-Deoxy-D-glucose

Chemical Name:2-Deoxy-D-glucose
CAS.NO:154-17-6
Synonyms:2-DEOXY-D-ARABINOHEXOSE;D-arabino-Hexose, 2-deoxy-;2-Deoxy-D-arabino-hexose;2-Deoxy-D-glucose;2-deoxy-d-arabino-hexos;MFCD00151328;D-Arabino-2-deoxyhexose;EINECS 205-823-0
Molecular Formula:C6H12O5
Molecular Weight:164.156
HS Code:2912491000

Physical and Chemical Properties:
Melting point:146-147ºC
Boiling point:456.7±45.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.534
PSA:97.99000
Exact Mass:164.068466
LogP:-3.07

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like 2-DEOXY-D-ARABINOHEXOSE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 205-823-0 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Deoxy-D-arabino-hexose Use and application,MFCD00151328 technical grade,usp/ep/jp grade.


Related News: Many domestic raw material pharmaceutical and intermediate manufacturing companies with strong capital and talent reserves and advanced technology and processes have developed in the country, and the competitiveness of market participants has continued to increase. 2-Deoxy-D-glucose manufacturer Many domestic raw material pharmaceutical and intermediate manufacturing companies with strong capital and talent reserves and advanced technology and processes have developed in the country, and the competitiveness of market participants has continued to increase. 2-Deoxy-D-glucose supplier With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow. 2-Deoxy-D-glucose vendor With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow. 2-Deoxy-D-glucose factory CROS NT built up its own biometric services portfolio: clinical data management, biostatistics, statistical programming and medical writing, through a series of acquisitions in the early 2010s. In 2013, CROS NT established a foothold in the U.S. with its purchase of Stat-Tech Services, which had a presence in the medical devices sector. CROS NT followed up the next year with its buy of biometrics services provider MDSL International to broaden its U.K. branch.